GHK-Cu holds no Health Canada authorization for human or veterinary use, and any application to a person or animal, including topical use outside the cosmetic-grade product framework, would step outside that designation
Use a new sterile needle for each injection Rotate sites to avoid tissue inflammation Inject subcutaneously for systemic use , intramuscularly near injury for targeted repair Following best practices ensures consistent absorption and reduces injection-related complications
95% CI: 0.100.50) and 1324 months after treatment initiation compared with pretreatment
RESEARCH STUDIES GHK-Cu Research Applications & Published Studies GHK-Cu research encompasses nearly five decades of published literature, spanning dermatological research, wound biology, and gene expression studies
The term lipotropic was first used in 1935 by a scientist studying the chemical reactions of fat in the liver, according to Iuventus Medical Center